Wednesday began with a political earthquake and ended with markets acting as if somebody had merely rearranged the furniture. Corners of the economy that live and die by policy suddenly had new homework to do before the opening bell. 

See which corners cheered, which winced, and what it all meant for the people actually holding the stocks.

One Nasdaq-listed company closed the acquisition that completed its model in February, quadrupled its workforce to over 400, and announced that Signals, its orchestration software and operational digital twin, is now alive and running around the clock at Knightscope Headquarters.

Preliminary Q3 revenue reached $8.7 million, up 177% year over year.

Market cap: roughly $11 million.

Unlock the full story now

*Examples that we provide of share price increases pertaining to a particular Issuer from one referenced date to another represent an arbitrarily chosen time period and are no indication whatsoever of future stock prices for that Issuer and are of no predictive value. Our stock profiles are intended to highlight certain companies for YOUR further investigation; they are NOT stock recommendations or constitute an offer or sale of the referenced securities.

Democrats won control of Congress, but investors cheered rather than panicked, taking comfort in President Trump saying he would accept the results and the prospect of gridlock on major economic policy.

Republican losses in the Texas and Ohio governors’ races could complicate data center plans, yet Amazon and Microsoft rallied on the idea that new roadblocks would protect incumbents. 

Drugmakers face more pricing oversight, though investors doubted it would change much.

Oil had its worst rout since April, with Brent settling below $100 for the first time in over a month after Vice President JD Vance tied the election losses to the Iran war and high energy prices.

Treasury yields slid too. Sequoia, meanwhile, is closing its London office and merging teams to play offense in the AI era.

Angi joined Google's AI Mode for home services searches, connecting homeowners with local service professionals through results that lead to Angi profiles, where users can review providers and request quotes for repairs, maintenance, and other home projects.

Adobe connected its CX Enterprise Coworker with major AI platforms, bringing marketing workflows into familiar tools including ChatGPT, Claude, Gemini and Microsoft Copilot, allowing teams to track campaign results & coordinate customer engagement across connected systems.

Moderna announced that its experimental Bundibugyo Ebola vaccine received a WHO advisory recommendation, supporting advancement into a larger efficacy study in the Democratic Republic of the Congo, with the planned Phase 2/3 evaluation still subject to regulatory approval.

Lexaria signed an agreement with an unnamed pharmaceutical company, testing its DehydraTECH drug delivery platform with the partner's proprietary molecules, creating a third pharmaceutical relationship that could lead to licensing discussions.

Dick's Sporting Goods signed a multi-year partnership with Caitlin Clark, covering both Dick's and Foot Locker as their first athlete brand partner, with plans spanning advertising campaigns, signature footwear and apparel promotions.

MasterCraft expanded its dealer network across North America and Europe, adding sales and service distribution partners, including 2 European MasterCraft dealers and 13 dealerships for its Crest and Balize pontoon brands, along with additional locations representing Chaparral and Robalo boats.

Something new is plugging into the power grid and draining it — something that can devour the electricity of 100,000 homes at once, likely being built in your state right now.  

In some states, bills are already up 20% in a year, and James Altucher believes that's just the start.  

So he's identified the one company in prime position to facilitate a plan that’ll let you flip this rate hike into a profit. 

Get the details in James' FREE briefing now.

Remitly expanded its Global Card nationwide, adding domestic transfers and payment requests through card balances, text messages, and payment links, while opening access to eligible U.S. customers beyond its initial invitation-only rollout.

Lemonade launched renters insurance in Minnesota, completing availability across all 50 states and Washington, D.C., with coverage starting at $5 monthly and policy purchases, coverage adjustments, and claims available through its app or website.

Voyager Technologies secured a $35 million NASA HUNCH contract, extending program management for 5 years while helping high school students design and manufacture spaceflight hardware, continuing a role the company has held since 2021.

Enviri finalized Harsco Rail's Deutsche Bahn exit, removing remaining railway equipment contract obligations after repaying approximately $73 million in advances, securing release of $13 million in performance bonds and approximately $49 million in restricted cash.

Cricut [CRCT] $8.88 (+48.74%)

Cricut, maker of the craft machines that rule hobbyists’ tables, crushed a lukewarm forecast: revenue of $188.6 million against $164.4 million expected and EPS of $0.13 against $0.05.

Product sales rose 17%, and international jumped 30%, against an easy year-ago comparison, lifting shares to levels not seen since fall 2023. Analysts braced for a shrug and got a masterpiece.

Lyell Immunopharma [LYEL] $15.43 (+43.27%)

Lyell Immunopharma raised about $80 million at $10.77 a share from backers including ARCH Venture Partners, RTW Investments and Adage Capital, and the stock treated the cash like a verdict.

The money carries lead cell therapy ronde-cel toward an FDA filing in the second half of 2027, with more data due at a December medical meeting and runway into 2028.

Advantage Solutions [ADV] $39.67 (+36.09%)

Advantage Solutions posted a per-share loss of $1.96 against a dime expected, yet revenue of $913.7 million edged past forecasts, and a $25 million restructuring plan gave bulls something to hold.

Trading was thin, with roughly 208,000 shares changing hands, so the move may say more about scarcity than conviction, and analysts on average still say hold.

Nurix Therapeutics [NRIX] $15.95 (-38.23%)

Nurix Therapeutics learned after Tuesday’s close that partner Sanofi is ending its oral STAT6 degrader program, SAR448272, and with it the milestones and royalties tied to that drug.

Sanofi offered no clear reason, and management says it never saw supporting data. Jefferies trimmed its target to $36 from $45, though Nurix still holds about $1.1 billion in cash.

Amdocs [DOX] $43.66 (-30.07%)

Amdocs matched fourth-quarter estimates, then guided next quarter’s revenue to about $975 million at the midpoint against $1.2 billion expected, and the stock fell off a cliff.

The culprit is a contract dispute with T-Mobile, with both sides alleging material breaches and floating termination or arbitration. Full-year adjusted EPS is now seen falling 26% to 30%.

Everus Construction Group [ECG] $79.71 (-29.29%)

Everus Construction posted what looks like a blowout: revenue up 40% to $1.38 billion, EPS of $1.79 against $0.78 expected, backlog up 86% and a raised outlook. Investors sold anyway.

Possible culprits are a one-time $7.6 million settlement flattering margins and guidance implying no further expansion. When expectations are sky-high, even a beat can feel like a miss.

One NASDAQ company is already delivering. 558% YoY revenue growth. Paid Air Force and Navy trials done. 26 acquisitions complete. Quantum defense initiative underway.

Stock at $199M while peers trade at $685M–$7B. Maxim has a $5 target.

Unlock the full story now

*Examples that we provide of share price increases pertaining to a particular Issuer from one referenced date to another represent an arbitrarily chosen time period and are no indication whatsoever of future stock prices for that Issuer and are of no predictive value. Our stock profiles are intended to highlight certain companies for YOUR further investigation; they are NOT stock recommendations or constitute an offer or sale of the referenced securities.

That's it for today! Please, write us back, and let us know what you think of the Closing Bell Roundup. We're always eager to hear feedback!

Thanks for reading. I'll see you at the next open! 

Best Regards,
— Adam G.
Elite Trade Club

Click here to get our daily newsletter straight to your cell for free.

P.S. Just like this newsletter, it's 100% free*, and you can stop at any time by replying STOP.